Steven P. Gelone - Jan 29, 2023 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Director
Signature
/s/ J. Christopher Naftzger, by power of attorney
Stock symbol
NBRV
Transactions as of
Jan 29, 2023
Transactions value $
-$210
Form type
4
Date filed
1/31/2023, 07:56 PM
Previous filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBRV Ordinary Shares Tax liability -$210 -140 -0.97% $1.50 14.3K Jan 29, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.